6-01-2026, 16:00

Hummingbird Bioscience Announces First Patient Dosed in Phase I Clinical Trial of HMBD-501 in Advanced HER3-Expressing Solid Malignancies

Notified -
Globe Newswire6-01-2026, 16:00
26-06-2025, 08:00

Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics

Notified -
Globe Newswire26-06-2025, 08:00
7-01-2025, 20:00

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

Notified -
Globe Newswire7-01-2025, 20:00
29-07-2024, 19:00

Hummingbird Bioscience Announces Key Leadership Appointments

Notified -
Globe Newswire29-07-2024, 19:00
13-05-2024, 16:30

Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024
Globe Newswire13-05-2024, 16:30